Organization
Hospital Clínico San Carlos
8 abstracts
Abstract
Detection of circulating tumor DNA following neoadjuvant chemotherapy and surgery to anticipate early relapse in ER positive and HER2 negative breast cancer: Analysis from the PENELOPE-B trial.Org: Royal Cancer Hospital, Heidelberg University, Department of Oncology, National Taiwan University Hospital, Asan Medical Center, Service de Oncología Médica,
Abstract
Development of a multiparametric prognostic score based on PAM50, in patients with HR+/HER2- advanced breast cancer (aBC) treated with endocrine therapy (ET) plus cyclin dependent kinase 4 and 6 inhibitors (CDKi), within the CDK-PREDICT (SOLTI-1801) study and HCB cohort.Org: SOLTI Cancer Research Group, August Pi i Sunyer Biomedical Research Institute, Hospital Clínic de Barcelona, IDIBAPS, Biomedical Research Institute INCLIVA, Hospital Universitario 12 de Octubre Research Institute,
Abstract
Imlunestrant, an oral selective estrogen receptor degrader (SERD), as monotherapy and in combination with abemaciclib, in endometrioid endometrial cancer (EEC): Results from the EMBER phase 1a/1b study.Org: Next Oncology Virginia and Virginia Cancer Specialists, Sir Charles Gairdner Hospital, Calvary Mater Hospital, University of Vermont Cancer Center, Stephenson Cancer Center,
Abstract
Progression-free survival as a surrogate endpoint of overall survival in advanced biliary tract cancer: A meta-analysis of randomized trials and individual-patient level correlation.Org: Vall d'Hebron Institute of Oncology, UGC Oncología Guipúzcoa, Hospital 12 de Octubre, Hospital Universitario Central de Asturias, Hospital Universitario Gregorio Marañón,
Abstract
Incidence of non-canonical IDH mutations and IDH co-mutations in a multicenter prospective study of patients with glioma.Org: Hospital Clinico Universitario San Carlos (IdISSC), Hospital Universitario San Carlos, Hospital Clinico Universitario San Carlos Instituto de Investigación Sanitaria San Carlos (IdISSC), Hospital Universitario La PaZ (IdiPAZ), Hospital Clínico San Carlos,
Abstract
Association of encapsulation of CDK12 inhibitor with anti-tumour activity in colon cancer cell lines.Org: Medical Oncology Department, Presidio Ospedaliero Santa Maria della Misericordia, Azienda Sanitaria Universitaria Friuli Centrale (ASUFC), Udine, Italy, Hospital Universitario Clínico San Carlos, Hospital Clínico San Carlos, Hospital Clínico San Carlos and IdISSC, Madrid, Spain, Instituto de Investigación Sanitaria Hospital Clínico San Carlos (IdISSC),
Abstract
A prospective, non-interventional study among patients diagnosed with locally advanced or metastatic non–small-cell lung cancer to assess the adherence to oral antineoplastic therapy from data collected through patient-reported questionnaires and tablets count in Spain: LOADH study.Org: Hospital Universitario Arnau de Vilanova, Lleida, Spain, Spain, Medicine Department, Santiago de Compostela University,
Abstract
A HEALTH CARE PROGRAM TO REDUCE RECENT DISABILITY DUE TO MUSCULOSKELETAL DISORDERS IN ELDERS: A PRELIMINARY ANALYSISOrg: Rheumatology, Hospital Clínico San Carlos, Spanish Foundation of Rheumatology, Primary Care Physicians, Health District 7,